News

Teknova Teams Up with Pluristyx to Enhance Cell Therapy Production

Teknova Teams Up with Pluristyx to Enhance Cell Therapy Production

Teknova and Pluristyx Partnership for Cell Therapy Innovation

HOLLISTER, Calif. – Teknova, known for its critical reagents in life sciences, has joined forces with Pluristyx to enhance the manufacturing of next-generation cell therapies. This collaboration aims to produce and distribute the PluriFreeze™ product line, which serves as both a cryopreservative and cell wash media system for developers of allogeneic cell therapies.

Transforming Cellular Biopreservation

Pluristyx has carved a niche in providing induced Pluripotent Stem Cells (iPSCs) and recognizes how crucial proper cellular biopreservation is throughout the cell therapy process. They’ve crafted a unique cryopreservation formulation that allows for systematic freezing of cells, thereby streamlining the cell product manufacturing process. By launching the PluriFreeze product line, they combine advanced cryopreservation with ease of use for companies focused on bringing these therapies to market.

Exclusive Production and Distribution

This partnership signifies that Teknova will serve as the exclusive manufacturer and distributor of PluriFreeze in the United States and Canada, broadening access for customers looking to utilize this groundbreaking product.

Voices Behind the Collaboration

Teknova's President and CEO, Stephen Gunstream, expressed enthusiasm about the collaboration, emphasizing how it unites Teknova’s operational strength with Pluristyx's innovative cryopreservation technology. He remarked that making PluriFreeze readily available will aid customers in streamlining their transition from research stages to clinical manufacturing.

Quality and Experience Matter

Pluristyx's CEO, Benjamin Fryer, noted that with Teknova’s 30 years of experience and an extensive customer base, they are poised perfectly to expand the reach of the PluriFreeze system. The focus on maintaining high cellular viability is critical not just for storage, but throughout every stage of the workflow in cell therapy development.

Understanding PluriFreeze

The PluriFreeze system offers both a synthetic base wash that resembles the intracellular environment and a unique low-viscosity freezing medium containing 10% dimethyl sulfoxide (DMSO). This combination enhances ease of scalability and process automation for manufacturers looking to accelerate their production processes.

Upcoming Announcements

More details about their collaboration and product specifics, including pricing and availability, will soon be revealed during the BioProcess International West conference. This occasion represents a significant opportunity for interested parties to gain insights into the progression of these innovative solutions.

About Teknova

Since its inception, Teknova has been committed to pushing the boundaries of reagent manufacturing to support the life sciences industry. Their customizable solutions help developers accelerate their work, from initial research to large-scale production. Located in Hollister, California, Teknova utilizes a state-of-the-art manufacturing platform to deliver high-quality reagents and media that are essential for new therapeutic advancements.

About Pluristyx

Pluristyx specializes in the development and manufacturing of cell and gene therapies, offering a suite of services that includes iPSC lines and genetic engineering technologies. Their focus on high-quality products is crucial for driving forward the clinical applications of transformative cell therapies.

Frequently Asked Questions

1. What is the purpose of the Teknova and Pluristyx collaboration?

The collaboration focuses on producing and commercializing the PluriFreeze product line, which supports the manufacturing of allogeneic cell therapies.

2. What benefits does PluriFreeze offer?

PluriFreeze enhances cellular biopreservation and simplifies the scale-up process for developers working on cell therapies.

3. How does Teknova contribute to this partnership?

Teknova serves as the exclusive manufacturer and distributor of PluriFreeze in the U.S. and Canada, leveraging their extensive experience and operational capabilities.

4. Where can more information about these products be found?

Detailed information will be available at the BioProcess International West conference and can also be accessed through Teknova's official channels.

5. How long has Teknova been in the life sciences industry?

Teknova has been innovating in the life sciences sector since 1996, focusing on reagent manufacturing and supporting various biomedical applications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 108

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
Cemig and Huawei's Bold Network Leap: Power Up

Updated Category News Views 40

Taking the Leap in Brazil's Power Grid In Brazil, energy distribution's a whole different beast, and boy, is it complicated! Cemig found out the hard way that relying on public networks was a risky bet. Consistently bad. With a measly 50% coverage in Brazil's vast lands, you're looking at a communications nightmare, especially in the back of beyond where grid faults could...

Continue Reading
OI Investors Crack Down: Class Action Filing Looms

Updated Category News Views 53

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Continue Reading
DEEPBLUE's Panelized Systems Target Low-Rise Markets

Updated Category News Views 28

Changing the Game in Low-Rise Construction Been around the block a few times and seen all sorts of hype in this industry, but what DEEPBLUE SMARTHOUSE is pushing sounds more like evolution than revolution for low-rise builds. They're leaning into this panelized building system like a boxer on the ropes—that's their strategy to keep things steady and predictable. The...

Continue Reading
TagMaster To Acquire Kapsch's RFID Ops in NA Market

Updated Category News Views 5

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

Continue Reading
SDI's Bhatt Celebrates Back-to-Back Chicago Titan Wins

Updated Category News Views 35

Second Year in a Row: A Nod to Visionary Leadership Hot off the press, folks. Hardik Bhatt, steering the ship at SDI Presence, is basking in the glory of a repeat recognition as a Chicago Titan 100 honoree. It's not just a headline; it's a testament to Bhatt's leadership prowess and how he plays the IT consultancy game. This isn't your run-of-the-mill award, but a salute...

Continue Reading
Cuisine.K Brings Korean Seafood to Seattle Spotlight

Updated Category News Views 17

Korean Seafood Makes Waves in Seattle Bring out the chopsticks, ‘cause Korean seafood just took Seattle by storm with the Cuisine.K Korean culinary showcase. Hosted by CJ Foods, alongside the Korea Fisheries Association, this event smacked the local food scene square in the face with the unique flavors and techniques of K-Seafood—from students all the way to seasoned...

Continue Reading
Procon Uses Robotics to Revamp Cruise Terminal 5

Updated Category News Views 15

Building Bigger with Robotics at Port Canaveral Robots on a construction site sounds like sci-fi, right? But it's the reality at Port Canaveral's Cruise Terminal 5, where Procon is rolling out its robotic tech magic. This ain't your everyday wrench-and-spanner job; we're talking remote-controlled bots capturing 360-degree images. “Regular reality capture can help teams...

Continue Reading
AI Use Hits 93% in Health Systems' Digital Shift

Updated Category News Views 26

Healthcare's AI Surge: Jumping the Adoption Hurdle The digital health landscape isn't just humming along—it's hitting high gear. AI, once the shiny toy in innovation's toolkit, is now a fixture in 93.2% of healthcare systems according to CHIME's latest findings. For anyone keeping score, that's a hefty leap and paints a picture where AI isn't just in the game, it's...

Continue Reading
Xavier Ochsner Opens State-of-the-Art Medical School

Updated Category News Views 106

A New Era for Medical Education in New Orleans If you're familiar with New Orleans, you know it's a city defined by its vibrancy, culture, and resilience. Well, the Xavier Ochsner College of Medicine is adding to that narrative with the opening of their spanking new Center for Medical Education. It's a project that promises to shake things up in the best possible way for...

Continue Reading

Top 5 Most Recently Viewed Articles

Ascletis Advances ASC47 with Encouraging Phase Ib Study Results

Updated Category News Views 313

Exciting Developments in ASC47 Research Ascletis Pharma Inc. is making significant strides in the realm of obesity treatment with its promising candidate, ASC47. This innovative drug is designed to be an adipose-targeted, muscle-preserving solution aimed at tackling obesity. Recent Phase Ib studies have provided compelling pharmacokinetic data and weight loss outcomes,...

Continue Reading
USAA Federal Savings Bank Ordered to Improve Safety Practices

Updated Category News Views 279

USAA Federal Savings Bank Faces Regulatory Scrutiny The U.S. Office of the Comptroller of the Currency (OCC) has recently directed USAA Federal Savings Bank to rectify several regulatory deficiencies classified as unsafe. These issues, which the bank has grappled with for a number of years, reflect gaps in management practices, earnings strategies, information technology...

Continue Reading
RoosterBio and Thermo Fisher Team Up for Advanced Cell Therapies

Updated Category News Views 379

RoosterBio and Thermo Fisher: A Game-Changing Collaboration RoosterBio, Inc., a prominent supplier of adult human mesenchymal stem/stromal cells (hMSCs), has announced a strategic collaboration with Thermo Fisher Scientific. This partnership aims to enhance the manufacturing processes for groundbreaking cell and exosome therapies, promising to make significant advances in...

Continue Reading
Nvidia's Datacenter Revenue Anticipations for Q4 Set to Surge

Updated Category News Views 136

Nvidia's Positive Outlook for Datacenter Revenues in Q4 Analysts from Bernstein are feeling optimistic about Nvidia’s (NASDAQ: NVDA) datacenter revenues as the fourth quarter approaches. Their analysis indicates that we can anticipate a significant rise in revenue, driven by recent advancements in Nvidia's product lineup. Insights from Recent Discussions After a...

Continue Reading
Impact of Financial Status on Longevity Among Older Adults

Updated Category News Views 194

Understanding Longevity Disparities Among Older Adults A recent analysis has revealed a stark reality concerning older adults and their financial stability. Research indicates that those earning $20,000 or less annually tend to die on average nine years earlier than individuals earning $120,000 or more. This significant disparity highlights the urgent need to address the...

Continue Reading